Are Serum Ferritin Levels a Reliable Cancer Biomarker? A Systematic Review and Meta-Analysis

References

• Moustarah F, Mohiuddin SS. Dietary Iron. Treasure Island (FL): StatPearls Publishing; 2020.
   Google Scholar
• Akiba S, Neriishi K, Blot WJ, Kabuto M, Stevens RG, Kato H, Land CE. Serum ferritin and stomach cancer risk among a Japanese population. Cancer. 1991;67(6):1707–12. doi:10.1002/1097-0142(19910315)67:6<1707::AID-CNCR2820670638>3.0.CO;2-C
   PubMed Web of Science ®Google Scholar
• Sangkhae V, Nemeth E. Regulation of the iron homeostatic hormone hepcidin. Adv Nutr. 2017;8(1):126–36. doi:10.3945/an.116.013961
   PubMed Web of Science ®Google Scholar
• MacKenzie EL, Iwasaki K, Tsuji Y. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10(6):997–1030. doi:10.1089/ars.2007.1893
   PubMed Web of Science ®Google Scholar
• Paul BT, Manz DH, Torti FM, Torti SV. Mitochondria and iron: current questions. Expert Rev Hematol. 2017;10(1):65–79. doi:10.1080/17474086.2016.1268047
   PubMed Web of Science ®Google Scholar
• Kalainayakan SP, FitzGerald KE, Konduri PC, Vidal C, Zhang L. Essential roles of mitochondrial and heme function in lung cancer bioenergetics and tumorigenesis. Cell Biosci. 2018;8:56 doi:10.1186/s13578-018-0257-8
   PubMed Web of Science ®Google Scholar
• Lui GY, Kovacevic Z, Richardson V, Merlot AM, Kalinowski DS, Richardson DR. Targeting cancer by binding iron: Dissecting cellular signaling pathways. Oncotarget. 2015;6(22):18748–79. doi:10.18632/oncotarget.4349
   PubMedGoogle Scholar
• Alkhateeb A, Zubritsky L, Kinsman B, Leitzel K, Campbell-Baird C, Ali SM, Connor J, Lipton A. Elevation in multiple serum inflammatory biomarkers predicts survival of pancreatic cancer patients with inoperable disease. J Gastrointest Cancer. 2014;45(2):161–7. doi:10.1007/s12029-013-9564-9
   PubMedGoogle Scholar
• Gao Y, Wang J, Zhou Y, Sheng S, Qian SY, Huo X. Evaluation of serum CEA, CA19-9, CA72-4, CA125 and ferritin as diagnostic markers and factors of clinical parameters for colorectal cancer. Sci Rep. 2018;8(1):2732. doi:10.1038/s41598-018-21048-y
   PubMed Web of Science ®Google Scholar
• Brown RAM, Richardson KL, Kabir TD, Trinder D, Ganss R, Leedman PJ. Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. Front Oncol. 2020;10:476. doi:10.3389/fonc.2020.00476
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097 doi:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi:10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Islam MM, Iqbal U, Walther B, Atique S, Dubey NK, Nguyen PA, Poly TN, Masud JH, Li YJ, Shabbir SA. Benzodiazepine use and risk of dementia in the elderly population: A systematic review and meta-analysis. Neuroepidemiology. 2016;47(3-4):181–91. doi:10.1159/000454881
   PubMed Web of Science ®Google Scholar
• Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11):1119–29. doi:10.1016/S0895-4356(00)00242-0
   PubMed Web of Science ®Google Scholar
• Goswami B, Rajappa M, Gupta N, Mahto M, Hadke NS, Mishra TK. Breast cancer: interaction between oxidant-antioxidant dynamics and inflammation in Indian females. Cancer Biomark. 2010;6(2):95–103. doi:10.3233/CBM-2009-0122
   PubMed Web of Science ®Google Scholar
• Güner G, Kirkali G, Yenisey C, Töre IR. Cytosol and serum ferritin in breast carcinoma. Cancer Lett. 1992;67(2/3):103–12. doi:10.1016/0304-3835(92)90132-F
   PubMed Web of Science ®Google Scholar
• Rajizadeh A, Mozaffari-Khosravi H, Zavar-Reza J, Shiryazdi SM. Comparison of hematological parameters, iron levels, and oxidative stress in women with and without breast cancer: A case- control study. Med J Islam Repub Iran. 2017;31:114 doi:10.14196/mjiri.31.114
   PubMedGoogle Scholar
• Gackowski D, Kruszewsk M, Banaszkiewicz Z, Jawien A, Olinski R. Lymphocyte labile iron pool, plasma iron, transferrin saturation and ferritin levels in colon cancer patients. Acta Biochim Pol. 2002;49(1):269–72.
   PubMed Web of Science ®Google Scholar
• Gür T, Demir H, Mç K. Tumor markers and biochemical parameters in colon cancer patients before and after chemotherapy. Asian Pac J Cancer Prev. 2011;12:3147–50.
   PubMedGoogle Scholar
• Cook MB, Kamangar F, Weinstein SJ, Albanes D, Virtamo J, Taylor PR, Abnet CC, Wood RJ, Petty G, Cross AJ, et al. Iron in relation to gastric cancer in the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev. 2012;21(11):2033–42. doi: 10.1158/1055-9965.
   PubMed Web of Science ®Google Scholar
• Bhatavdekar JM, Vora HH, Goyal A, Shah NG, Karelia NH, Trivedi SN. Significance of ferritin as a marker in head and neck malignancies. Tumori. 1987;73(1):59–63.
   PubMed Web of Science ®Google Scholar
• Ho S, Leung SF, Leung WT, Tsao SY, Kwan WH, Choi P, Johnson PJ. Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol. 1996;32B(4):242–5. doi:10.1016/0964-1955(95)00084-4
   PubMed Web of Science ®Google Scholar
• Maxim PE, Veltri RW. Serum ferritin as a tumor marker in patients with squamous cell carcinoma of the head and neck. Cancer. 1986;57(2):305–11. doi:10.1002/1097-0142(19860115)57:2 < 305::aid-cncr2820570219 > 3.0.co;2-d
   PubMed Web of Science ®Google Scholar
• Richie JPJ, Kleinman W, Marina P, Abraham P, Wynder EL, Muscat JE. Blood iron, glutathione, and micronutrient levels and the risk of oral cancer. Nutr Cancer. 2008;60(4):474–82. doi:10.1080/01635580801956477
   PubMed Web of Science ®Google Scholar
• Vinzenz K, Schönthal E, Zekert F, Wunderer S. Diagnosis of head and neck carcinomas by means of immunological tumour markers (Beta-2-microglobulin, immunoglobulin E, ferritin, N-acetyl-neuraminic acid, phosphohexose-isomerase). J Craniomaxillofac Surg. 1987;15(5):270–7. doi:10.1016/s1010-5182(87)80066-5
   PubMed Web of Science ®Google Scholar
• Yuan C, Yang K, Tang H, Chen D. Diagnostic values of serum tumor markers Cyfra21-1, SCCAg, ferritin, CEA, CA19-9, and AFP in oral/oropharyngeal squamous cell carcinoma. OTT. 2016;9:3381–6. doi:10.2147/OTT.S105672
   Web of Science ®Google Scholar
• Giannoulis E, Arvanitakis C, Nikopoulos A, Doutsos I, Tourkantonis A. Diagnostic value of serum ferritin in primary hepatocellular carcinoma. Digestion. 1984;30(4):236–41. doi:10.1159/000199114
   PubMed Web of Science ®Google Scholar
• Tatsuta M, Yamamura H, Iishi H, Kasugai H, Okuda S. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma. Oncology. 1986;43(5):306–10. doi:10.1159/000226388
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang M, Cui C, Zhang L, Liao F, Li H, Wu X. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma. CBM. 2015;15(5):677–83. doi:10.3233/CBM-150508
   Web of Science ®Google Scholar
• Alexandrakis MG, Passam FH, Perisinakis K, Ganotakis E, Margantinis G, Kyriakou DS, Bouros D. Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respir Med. 2002;96(8):553–8. doi:10.1053/rmed.2002.1328
   PubMed Web of Science ®Google Scholar
• Gulen ST, Karadag F, Karul AB, Kilicarslan N, Ceylan E, Kuman NK, Cildag O. Adipokines and systemic inflammation in weight-losing lung cancer patients. Lung. 2012;190(3):327–32. doi:10.1007/s00408-011-9364-6
   PubMed Web of Science ®Google Scholar
• Shi HB, Li XD, Jiang JT, Zhao WQ, Ji M, Wu CP. Serum ferritin is elevated in advanced non-small cell lung cancer patients and is associated with efficacy of platinum-based chemotherapy. J Cancer Res Ther. 2014;10:681–5. doi:10.4103/0973-1482.139156
   PubMed Web of Science ®Google Scholar
• Ji M, Li XD, Shi HB, Ning ZH, Zhao WQ, Wang Q, Zhu LN, Liu Y, Wu CP. Clinical significance of serum ferritin in elderly patients with primary lung carcinoma. Tumour Biol. 2014;35(10):10195–9. doi:10.1007/s13277-014-2317-y
   PubMedGoogle Scholar
• Sukiennicki GM, Marciniak W, Muszyńska M, Baszuk P, Gupta S, Białkowska K, Jaworska-Bieniek K, Durda K, Lener M, Pietrzak S, et al. Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence. PLoS One. 2019;14(1):e0208610. doi:10.1371/journal.pone.0208610
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang Y, Sun L, Wang S, Nie J, Zhao W, Zheng G. Evaluation of the clinical application of multiple tumor marker protein chip in the diagnostic of lung cancer. J Clin Lab Anal. 2018;32(8):e22565. doi:10.1002/jcla.22565
   PubMed Web of Science ®Google Scholar
• Luger TA, Linkesch W, Knobler R, Kokoschka EM. Serial determination of serum ferritin levels in patients with malignant melanoma. Oncology. 1983;40(4):263–7. doi:10.1159/000225740
   PubMed Web of Science ®Google Scholar
• Sezgi C, Taylan M, Sen HS, Evliyaoğlu O, Kaya H, Abakay O, Abakay A, Tanrıkulu AC, Senyiğit A. Oxidative status and acute phase reactants in patients with environmental asbestos exposure and mesothelioma. Scient World J. 2014;2014:1–5. doi:10.1155/2014/902748
   Web of Science ®Google Scholar
• Lodh M, Goswami B, Gupta N, Patra SK, Saxena A. Assessment of oxidative stress and inflammatory process in patients of multiple myeloma. Indian J Clin Biochem. 2012;27(4):410–3. doi:10.1007/s12291-012-0222-y
   PubMedGoogle Scholar
• Macciò A, Madeddu C, Massa D, Mudu MC, Lusso MR, Gramignano G, Serpe R, Melis GB, Mantovani G. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. Blood. 2005;106(1):362–7. doi:10.1182/blood-2005-01-0160
   PubMed Web of Science ®Google Scholar
• Pinto V, Marinaccio M, Garofalo S, Vittoria Larocca AM, Geusa S, Lanzilotti G, Orsini G. Preoperative evaluation of ferritinemia in primary epithelial ovarian cancer. Tumori. 1997;83(6):927–9.
   PubMed Web of Science ®Google Scholar
• Nitti D, Fabris C, Del Favero G, Farini R, Grassi F, Farini A, Baccaglini U, Pedrazzoli S, Piccoli A, Lise M, et al. Serum ferritin in pancreatic disease. An accurate test of malignancy? Digestion. 1982;25(4):258–62. doi:10.1159/000198842
   PubMed Web of Science ®Google Scholar
• Fabris C, Farini R, Del Favero G, Grassi F, Nitti D, Piccoli A, Brosolo P, Naccarato R. Combined evaluation of serum ribonuclease and ferritin: any advantages in pancreatic cancer diagnosis? Oncology. 1984;41(6):393–5. doi:10.1159/000225861
   PubMed Web of Science ®Google Scholar
• Kuvibidila S, Gauthier T, Warrier RP, Rayford W. Increased levels of serum transferrin receptor and serum transferrin receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores. J Lab Clin Med. 2004;144(4):176–82. doi:10.1016/j.lab.2004.03.017
   PubMed Web of Science ®Google Scholar
• Essen A, Ozen H, Ayhan A, Ergen A, Tasar C, Remzi F. Serum ferritin: a tumor marker for renal cell carcinoma. J Urol. 1991;145(6):1134–7. doi:10.1016/s0022-5347(17)38555-5
   PubMed Web of Science ®Google Scholar
• Ozen H, Uygur C, Sahin A, Tekgül S, Ergen A, Remzi D. Clinical significance of serum ferritin in patients with renal cell carcinoma. Urology. 1995;46(4):494–8. doi:10.1016/S0090-4295(99)80261-1
   PubMed Web of Science ®Google Scholar
• Singh KJ, Singh SK, Suri A, Vijjan V, Goswami AK, Khullar M. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage. Indian J Cancer. 2005;42(4):197–200.
   PubMedGoogle Scholar
• Stroud J. A mechanistic theory explaining hyperferritinaemia in haemophagocytic lymphohistiocytosis. Med Hypotheses. 2019;122:165–71. doi:10.1016/j.mehy.2018.11.015
   PubMed Web of Science ®Google Scholar
• Alkhateeb AA, Han B, Connor JR. Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Res Treat. 2013;137(3):733–44. doi:10.1007/s10549-012-2405-x
   PubMed Web of Science ®Google Scholar
• Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res. 2018;28(3):265–80. doi:10.1038/cr.2017.155
   PubMed Web of Science ®Google Scholar
• Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F. Ferroptosis and cancer: Mitochondria meet the "iron maiden" cell death. Cells. 2020;9:1505. doi:10.3390/cells9061505
   PubMed Web of Science ®Google Scholar
• Torti SV, Manz DH, Paul BT, Blanchette-Farra N, Torti FM. Iron and cancer. Annu Rev Nutr. 2018;38:97–125. doi:10.1146/annurev-nutr-082117-051732
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Chang VC, Cotterchio M, Khoo E. Iron intake, body iron status, and risk of breast cancer: a systematic review and meta-analysis. BMC Cancer. 2019;19(1):543 doi:10.1186/s12885-019-5642-0
   PubMed Web of Science ®Google Scholar
• Ellidag HY, Eren E, Akdag M, Giray O, Kiraz K, Yilmaz N, Central Laboratories of Antalya Training and Research Hospital, University of Medical Sciences, Ministry of Health, Antalya, Turkey. The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender. UkrBiochem J. 2016;88(6):76–86. doi:10.15407/ubj88.06.076
   Google Scholar
• Yu Q, Zhou Y, Suturina L, Jaisamrarn U, Lu D, Parke S. Efficacy and safety of estradiol valerate/dienogest for the management of heavy menstrual bleeding: a multicenter, double-blind, randomized, Placebo-Controlled, Phase III Clinical Trial. J Womens Health (Larchmt). 2018;27(10):1225–32. doi:10.1089/jwh.2017.6522
   PubMed Web of Science ®Google Scholar
• Hu Z, Wang L, Han Y, Li F, Zheng A, Xu Y, Wang F, Xiao B, Chen C, Tao Z. Ferritin: A potential serum marker for lymph node metastasis in head and neck squamous cell carcinoma. Oncol Lett. 2019;17(1):314–22. doi:10.3892/ol.2018.9642
   PubMed Web of Science ®Google Scholar
• Schneider C, Bodmer M, Jick SS, Meier CR. Colorectal cancer and markers of anemia. Eur J Cancer Prev. 2018;27(6):530–8. doi:10.1097/CEJ.0000000000000397
   PubMed Web of Science ®Google Scholar
• Feng Z, Chen JW, Feng JH, Shen F, Cai WS, Cao J, Xu B. The association between serum ferritin with colorectal cancer. Int J Clin Exp Med. 2015;8(12):22293–9.
   PubMed Web of Science ®Google Scholar
• Wang X, An P, Zeng J, Liu X, Wang B, Fang X, Wang F, Ren G, Min J. Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer. Oncotarget. 2017;8(11):17862–72. doi:10.18632/oncotarget.14977
   PubMedGoogle Scholar